SCHEMBL4695582

SCHEMBL4695582

N#Cc1cnn2c(Cl)c(-c3c(F)cccc3Cl)c(Cl)nc12

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CSNK2A1 P68400 6/20 0.39
LMNA P02545 2/20 0.39
TSHR P16473 1/20 0.39
KDM4D Q6B0I6 1/20 0.38
ALDH1A1 P00352 5/20 0.38
KDM4E B2RXH2 5/20 0.38
HPGD P15428 3/20 0.38
GLA P06280 1/20 0.38
MAPK1 P28482 1/20 0.38
HSD17B10 Q99714 1/20 0.38
CDK2 P24941 2/20 0.37
MAPKAPK2 P49137 1/20 0.37
NPSR1 Q6W5P4 1/20 0.35
HTT P42858 2/20 0.35
TYK2 P29597 1/20 0.35
CLK4 Q9HAZ1 1/20 0.34
POLB P06746 1/20 0.34
RXFP1 Q9HBX9 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14463715 0.82 ALDH1A1 (0.46) CSNK2A1LMNATSHRKDM4DALDH1A1
SCHEMBL5233173 0.81 KDM4E (0.48) CSNK2A1LMNATSHRKDM4DALDH1A1
SCHEMBL14257400 0.81 LMNA (0.40) CSNK2A1LMNATSHRKDM4DALDH1A1
SCHEMBL5230928 0.81 KDM4D (0.43) CSNK2A1LMNAKDM4DALDH1A1KDM4E
SCHEMBL5594559 0.81 CSNK2A1 (0.43) CSNK2A1LMNAKDM4DALDH1A1KDM4E
SCHEMBL4693069 0.79 PDE2A (0.41) CSNK2A1LMNATSHRALDH1A1KDM4E
SCHEMBL4691830 0.77 CSNK2A1 (0.46) CSNK2A1LMNAKDM4DALDH1A1KDM4E
SCHEMBL18863648 0.76 CDK2 (0.45) CSNK2A1LMNAKDM4DALDH1A1KDM4E
SCHEMBL4507101 0.74 KDM4E (0.46) LMNATSHRALDH1A1KDM4EHPGD
SCHEMBL4695611 0.72 CSNK2A1 (0.41) CSNK2A1LMNAKDM4DALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1694681-B1 PYRAZOLOPYRIMIDINES BAYER CROPSCIENCE AG (DE) 2008-03-12 EP disclosed
US-20060276478-A1 Pyrazolopyrimidines BAYER CROPSCIENCE AG (DE) 2006-12-07 US disclosed
EP-1694681-A1 PYRAZOLOPYRIMIDINES Bayer CropScience AG (DE) 2006-08-30 EP disclosed
WO-2005056556-A1 PYRAZOLOPYRIMIDINES BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2005-06-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060276478-A1 Pyrazolopyrimidines Q6ZSR9, RPLP2, DPYD CSNK2A1 3066/4885LMNA 4800/4885TSHR 1348/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.